Search for Clinical Trial Results

Endometrial Neoplasms - 24 Studies Found
Status | Study |
Completed |
Study Name: Follow-up Care After Treatment for Endometrial Cancer Condition: Endometrial Neoplasm Date: 2008-09-09 |
Recruiting |
Study Name: The Role of Indocyanine Green to Identify Sentinel Lymph Node in Uterine Cancer Condition: Endometrial Neoplasm Date: 2016-06-24 Interventions: Procedure: Sentinel lymph node mapping Before laparoscopic hysterectomy and lymphadenectomy procedure fo |
Withdrawn |
Study Name: Lenvatinib in Second Line Endometrial Carcinoma Condition: Endometrial Neoplasms Date: 2016-08-18 Interventions:
|
Recruiting |
Study Name: Phase 2 Study of MLN0128, Combination of MLN0128 With MLN1117, Paclitaxel and Combination of MLN0128 With Paclitaxel in Women With Endometrial Cancer Condition: Endometrial Neoplasms Date: 2016-03-28 Interventions:
|
Completed |
Study Name: Studies of the Tumour Suppressor Gene PTEN - Endometrial Cancer Condition: Endometrial Neoplasms Date: 2011-02-11 Interventions:
|
Recruiting |
Study Name: Sentinel Lymph Node Detection in Endometrial Cancer Condition: Endometrial Neoplasms Date: 2015-11-05 Interventions: Procedure: Sentinel node procedure Patients with Endometrial cancer undergo Sentinel node procedure usin |
Recruiting |
Study Name: Indocyanine Green Versus Blue Dye for Detection of Sentinel Lymph Node In Endometrial Cancer Condition: Endometrial Neoplasms Date: 2015-09-29 Interventions: Procedure: Sentinel lymph node biopsy |
Active, not recruiting |
Study Name: The Feasibility Study of the Li Brush for the Screening of Endometrial Cancer in the Postmenopausal Period Condition: Endometrial Neoplasms Date: 2015-07-08 |
Completed |
Study Name: Diet and Physical Activity in Uterine Cancer Survivors Condition: Endometrial Neoplasms Date: 2015-04-20 Interventions: Behavioral: Shape-Up following cancer treatment The programme is based on "Social Cognitive Theory& |
Withdrawn |
Study Name: Ponatinib in the Treatment of FGFR Mutation Positive Recurrent or Persistent Endometrial Carcinoma Condition: Endometrial Neoplasms Date: 2013-06-25 Interventions: Drug: Ponatinib Ponatinib 45 mg daily for 4 weeks (4 weeks equal one cycle) |